SHAPE Society

1. Stefanadis C et al, J Am Col Cardiol 2001 April
ΔΤ - Percutanenous Coronary InterventionsΔΤ - Percutanenous Coronary Interventions

2. Coronary Thermography
• Thermal heterogeneity exists in vivo in
atherosclerotic plaque
• Statins decrease thermal heterogeneity possibly
by anti-inflammatory mechanism
• Thermal heterogeneity in the culprit lesion is a
prognostic factor for adverse cardiac events after
percutaneous interventions
• Is thermal heterogeneity a sensitive marker for
future cardiac events?

3. Primary end point: Death, MI, TLR in 12 months
Secondary end points:
-Procedural complications
-Cost effectiveness over 12 months
Stenting of culprit lesion only Stenting of culprit + non-culprit lesions
Randomization
Non-culprit lesion(s) with > 0.10O
C ∆T
Patients with ACS and multivessel disease
THERMO ACS:
Culprit or Multivessel Revascularization based on
Thermography in patients with ACS

4. …… Thermography Beyond Coronary ArteriesThermography Beyond Coronary Arteries